869-09-0

Basic information

• Product Name: 869-09-0
• Synonyms: Pentanedioic acid, 2,4-dibromo-, dimethyl ester;Dimethyl 2,4-dibromopentanedioate;2,4-Dibromo-Pentanedioic Acid Dimethyl Ester(WX630083)
• CAS NO: 869-09-0
• Molecular Formula: C₇H₁₀Br₂O₄
• Molecular Weight: 317.9599
• Mol File: 869-09-0.mol
• Article Data: 7

Chemical Properties

• Appearance: /
• Storage Temp.: Sealed in dry,Room Temperature
• CAS DataBase Reference: 869-09-0(CAS DataBase Reference)
• NIST Chemistry Reference: 869-09-0(869-09-0)
• EPA Substance Registry System: 869-09-0(869-09-0)

Safety Data

• Hazardous Substances Data: 869-09-0(Hazardous Substances Data)

Usage

General Description

Chemical compound 869-09-0 is also known as 3,5-Dimethoxybenzoic acid. It is a derivative of benzoic acid, containing two methoxy groups attached at the 3 and 5 positions of the benzene ring. 869-09-0 is commonly used in organic synthesis and chemical research as a building block for the synthesis of various biologically active compounds. It has been studied for its potential pharmacological and medicinal properties, particularly in the development of new drugs. Additionally, 3,5-Dimethoxybenzoic acid is also used as a chemical intermediate in the manufacture of pharmaceuticals and other organic compounds. Its properties and applications make it an important and versatile compound in the field of chemistry and pharmaceutical research.

Upstream product

• 67-56-1 methanol 
• 110-94-1 1,5-pentanedioic acid 
• 2873-74-7 gloutaric dichloride 
• 186581-53-3 diazomethane 
• 3479-80-9 α,α'-dibromoglutaric acid 
• 3425-64-7 d,l-α,α'-dibromoglutaric acid 
• 124-41-4 sodium methylate 

Downstream Products

• 826-34-6 dimethyl cis-cyclopropane-1,2-dicarboxylate 
• 826-35-7 dimethyl trans-1,2-cyclopropanedicarboxylate 
• 121049-90-9 cis-1-benzylazetidine-2,4-dicarboxylic acid dimethyl ester 
• 121049-90-9 trans-1-benzylazetidine-2,4-dicarboxylic acid dimethyl ester 
• 928853-01-4 2-(5-benzyl-tetrazol-2-yl)-4-bromo-pentanedioic acid dimethyl ester 
• 928852-99-7 2-bromo-4-(5-phenyl-tetrazol-2-yl)-pentanedioic acid dimethyl ester 
• 928853-05-8 5-oxo-4-(5-phenyl-tetrazol-2-yl)-pyrrolidine-2-carboxylic acid methyl ester 
• 928853-07-0 4-(5-benzyl-tetrazol-2-yl)-5-oxo-pyrrolidine-2-carboxylic acid methyl ester 
• 928853-02-5 2-azido-4-(5-phenyl-tetrazol-2-yl)-pentanedioic acid dimethyl ester 
• 928853-04-7 2-azido-4-(5-benzyl-tetrazol-2-yl)-pentanedioic acid dimethyl ester 
• 869494-18-8 6-propionyl-3,6-diazabicyclo[3.1.1]heptane 
• 869494-13-3 3-benzyl-3,6-diazabicyclo[3.1.1]heptan-2-one 

Relevant articles and documents

Structural characterization of 1,3-propanedithiols that feature carboxylic acids: Homologues of mercury chelating agents

The molecular structures of a series of 1,3-propanedithiols that contain carboxylic acid groups, namely rac- and meso-2,4-dimercaptoglutaric acid (H 4DMGA) and 2-carboxy-1,3-propanedithiol (H3DMCP), have been determined by X-ray diffraction. Each compound exhibits two centrosymmetric intermolecular hydrogen bonding interactions between pairs of carboxylic acid groups, which result in a dimeric structure for H3DMCP and a polymeric tape-like structure for rac- and meso-H4DMGA. Significantly, the hydrogen bonding motifs observed for rac- and meso-H 4DMGA are very different to those observed for the 1,2-dithiol, rac-2,3-dimercaptosuccinic acid (rac-H4DMSA), in which the two oxygen atoms of each carboxylic acid group hydrogen bond to two different carboxylic acid groups, thereby resulting in a hydrogen bonded sheet-like structure rather than a tape. Density functional theory calculations indicate that 1,3-dithiolate coordination to mercury results in larger S-Hg-S bond angles than does 1,2-dithiolate coordination, but these angles are far from linear. As such, κ2-S2 coordination of these dithiolate ligands is expected to be associated with mercury coordination numbers of greater than two. In vivo studies demonstrate that both rac-H4DMGA and H 3DMCP reduce the renal burden of mercury in rats, although the compounds are not as effective as either 2,3-dimercaptopropane-1-sulfonic acid (H3DMPS) or meso-H4DMSA.

3,6-DIAZABICYCLOS[3.1.1]HEPTANE DERIVATIVES WITH ANALGESIC ACTIVITY

The invention relates to compounds of general formula (I), wherein R and R1, different from one another, are: a C2-C8 straight or branched acyl group; and a group of formula (II), wherein B and R2 are as defined in the description. The compounds (I) have higher central analgesic activity than morphine and are substantially free from the side effects of morphine or other central analgesics. The invention further relates to a process for the preparation of the compounds (I).

Azetidine derivatives to treat memory and learning disorders

This invention relates to novel azetidines and derivatives thereof, as well as to pharmaceutical compositions and methods of treating memory and learning disorders. Another aspect of the invention relates to a method of utilizing the compounds and composi